Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. With the exact phrase: teva canada
Share this search Create an alert

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (50)
Results: 1-50 | Export
  1. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Michael Sine, General Manager
    Registration: 36 of 36 (2024-01-18 to present)
    Posted: 2024-02-20
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  2. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Michael Sine, General Manager
    Registration: 35 of 36 (2024-01-02 to 2024-01-18)
    Posted: 2024-01-02
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  3. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Michael Sine, General Manager
    Registration: 34 of 36 (2023-07-18 to 2024-01-02)
    Posted: 2023-07-18
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  4. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Michael Sine, General Manager
    Registration: 33 of 36 (2023-02-28 to 2023-07-18)
    Posted: 2023-02-28
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  5. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Michael Sine, VP and General Manager
    Registration: 32 of 36 (2022-09-01 to 2023-02-28)
    Posted: 2022-09-01
    Subject matter details: 8
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  6. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Michael Sine, VP and General Manager
    Registration: 31 of 36 (2022-07-26 to 2022-09-01)
    Posted: 2022-08-31
    Subject matter details: 8
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  7. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 30 of 36 (2022-05-17 to 2022-07-26)
    Posted: 2022-05-17
    Subject matter details: 8
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  8. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 29 of 36 (2021-08-12 to 2022-05-17)
    Posted: 2021-08-13
    Subject matter details: 8
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  9. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: Pierre Cyr, FleishmanHillard HighRoad Corp
    Registration: 1 of 1 (2021-02-01 to 2022-02-11)
    Posted: 2021-02-05
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  10. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 28 of 36 (2020-08-12 to 2021-08-12)
    Posted: 2020-08-13
    Subject matter details: 8
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  11. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 5 of 5 (2020-08-05 to 2021-02-16)
    Posted: 2020-08-06
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  12. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 27 of 36 (2020-07-08 to 2020-08-12)
    Posted: 2020-07-08
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  13. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 26 of 36 (2020-06-26 to 2020-07-08)
    Posted: 2020-06-26
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  14. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 3 of 3 (2020-03-27 to 2020-08-04)
    Posted: 2020-03-27
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  15. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 2 of 3 (2020-02-03 to 2020-03-27)
    Posted: 2020-02-04
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  16. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 25 of 36 (2019-11-28 to 2020-06-26)
    Posted: 2019-11-29
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  17. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 24 of 36 (2019-06-14 to 2019-11-28)
    Posted: 2019-06-14
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  18. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 1 of 3 (2019-04-29 to 2019-10-31)
    Posted: 2019-04-29
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  19. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Evan Wiseman, Counsel Public Affairs Inc.
    Registration: 1 of 1 (2019-04-29 to 2019-10-31)
    Posted: 2019-04-29
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  20. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 1 of 1 (2019-04-29 to 2019-10-31)
    Posted: 2019-04-29
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  21. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 4 of 5 (2019-04-18 to 2020-08-05)
    Posted: 2019-04-24
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  22. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 23 of 36 (2018-12-18 to 2019-06-14)
    Posted: 2018-12-18
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  23. Teva Canada Limited
    Type: Consultant
    Lobbyist: Julian Worsley, Miller Thomson LLP
    Registration: 1 of 1 (2018-11-09 to 2020-04-03)
    Posted: 2018-11-28
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  24. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 22 of 36 (2018-07-12 to 2018-12-18)
    Posted: 2018-07-12
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  25. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Christine Poulin, Senior Vice President and General Manager
    Registration: 21 of 36 (2018-04-01 to 2018-07-12)
    Posted: 2018-05-01
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  26. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 20 of 36 (2018-02-13 to 2018-04-01)
    Posted: 2018-02-13
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  27. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 19 of 36 (2017-12-01 to 2018-02-13)
    Posted: 2017-12-01
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  28. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 3 of 5 (2017-11-02 to 2019-04-18)
    Posted: 2017-11-07
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  29. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 2 of 5 (2017-06-04 to 2017-11-02)
    Posted: 2017-06-05
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  30. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 18 of 36 (2017-02-10 to 2017-12-01)
    Posted: 2017-02-10
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  31. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 1 of 5 (2016-11-22 to 2017-06-04)
    Posted: 2016-12-07
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  32. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 17 of 36 (2016-08-25 to 2017-02-10)
    Posted: 2016-08-25
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  33. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 16 of 36 (2016-07-13 to 2016-08-25)
    Posted: 2016-07-13
    Subject matter details: 7
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  34. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: Deanna Rudiak, The CG Group
    Registration: 1 of 1 (2016-05-19 to 2016-11-16)
    Posted: 2016-05-19
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  35. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: DONALD GRACEY, CG MANAGEMENT & COMMUNICATIONS
    Registration: 1 of 1 (2016-05-10 to 2016-11-16)
    Posted: 2016-05-12
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  36. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 15 of 36 (2016-01-06 to 2016-07-13)
    Posted: 2016-01-07
    Subject matter details: 7
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  37. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 14 of 36 (2015-07-20 to 2016-01-06)
    Posted: 2015-08-12
    Subject matter details: 7
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  38. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 13 of 36 (2015-03-31 to 2015-07-20)
    Posted: 2015-03-31
    Subject matter details: 6
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  39. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 12 of 36 (2014-08-20 to 2015-03-31)
    Posted: 2014-08-20
    Subject matter details: 5
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  40. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Douglas Sommerville, Senior Vice President and General Manager
    Registration: 11 of 36 (2014-01-01 to 2014-08-20)
    Posted: 2014-02-11
    Subject matter details: 5
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  41. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 10 of 36 (2013-09-20 to 2014-01-01)
    Posted: 2013-09-25
    Subject matter details: 5
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  42. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 9 of 36 (2013-04-23 to 2013-09-20)
    Posted: 2013-05-07
    Subject matter details: 5
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  43. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 8 of 36 (2012-08-31 to 2013-04-23)
    Posted: 2012-09-04
    Subject matter details: 5
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  44. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 7 of 36 (2012-06-26 to 2012-08-31)
    Posted: 2012-06-27
    Subject matter details: 5
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  45. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 6 of 36 (2012-03-15 to 2012-06-26)
    Posted: 2012-03-19
    Subject matter details: 5
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  46. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 5 of 36 (2011-12-06 to 2012-03-15)
    Posted: 2012-02-03
    Subject matter details: 5
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  47. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 4 of 36 (2011-09-14 to 2011-12-06)
    Posted: 2011-09-15
    Subject matter details: 5
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  48. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 3 of 36 (2011-04-11 to 2011-09-14)
    Posted: 2011-04-12
    Subject matter details: 4
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  49. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Responsible officer: Barry Fishman, President & Chief Executive Officer
    Registration: 2 of 36 (2010-11-15 to 2011-04-11)
    Posted: 2010-11-16
    Subject matter details: 4
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  50. Teva Novopharm
    Type: In-house Corporation
    Responsible officer: Barry Fishman, president & Chief Executive Officer
    Registration: 1 of 36 (2009-01-13 to 2009-09-03)
    Posted: 2009-03-11
    Subject matter details: 4
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1

Monthly communication reports (108)
Results: 1-50 | Export
  1. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2021-11-09
    Posted: 2021-12-14
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  2. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2021-11-08
    Posted: 2021-12-14
    Designated public office holders:
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies, Health Canada | Health Canada (HC)
    Subject matters:
    • Health
  3. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: Pierre Cyr, FleishmanHillard HighRoad Corp
    Occurred: 2021-11-08
    Posted: 2021-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Brancy | Health Canada (HC)
    Subject matters:
    • Health
  4. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2021-08-17
    Posted: 2021-09-14
    Designated public office holders:
    • Darryl Patterson, Director General, Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    • Rione Novak, Director, Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
  5. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: Pierre Cyr, FleishmanHillard HighRoad Corp
    Occurred: 2021-08-17
    Posted: 2021-09-15
    Designated public office holders:
    • Darryl Patterson, Director General, Biomanufacturing Sector Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    • Rione Novak, Director, Biomanufacturing Sector Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
  6. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2021-07-28
    Posted: 2021-08-12
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  7. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2021-04-09
    Posted: 2021-05-15
    Designated public office holders:
    • Sheryl Groeneweg, Director General, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
  8. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: Pierre Cyr, FleishmanHillard HighRoad Corp
    Occurred: 2021-04-09
    Posted: 2021-05-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Sheryl Groeneweg, Director General, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
  9. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-11-12
    Posted: 2020-12-15
    Designated public office holders:
    • Steve Verheul, Assistant Deputy Minister, Trade Policy and Negotiation | Global Affairs Canada (GAC)
    Subject matters:
    • International Trade
  10. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-11-09
    Posted: 2020-12-15
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • David Lee, Chief Regulatory Officer, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  11. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-11-06
    Posted: 2020-12-15
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Intellectual Property
    • Health
    • Industry
  12. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-11-03
    Posted: 2020-12-15
    Designated public office holders:
    • Amanda Woodley, Special Assistant (Policy) Assistant (Parliamentary Secretary) | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Industry
  13. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-07-14
    Posted: 2020-08-15
    Designated public office holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Stefania Trombetti, Assistant Deputy Minister, Regulatory Operations and Enforcement Branch | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
    • International Trade
    • Government Procurement
    • Industry
  14. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-07-03
    Posted: 2020-08-15
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister, Regulatory Operations and Enforcement Branch | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Kendal Weber, Assistant Deputy Minister, Strategy Policy Branch | Health Canada (HC)
    Subject matters:
    • International Trade
    • Government Procurement
    • Industry
    • Health
  15. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2020-02-11
    Posted: 2020-03-16
    Designated public office holders:
    • Ryan Dunn, Chief of Staff, Minister Bains' office | Innovation, Science and Economic Development Canada (ISED)
    • Bianca Hossain, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
  16. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Occurred: 2020-02-11
    Posted: 2020-03-13
    Designated public office holders:
    • Ryan Dunn, Chief of Staff, Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    • Bianca Hossain, Special Assistant (Policy), Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
  17. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2019-06-27
    Posted: 2019-07-15
    Designated public office holders:
    • Monique Lugli, Chief of Staff, Minister of Health | Health Canada (HC)
    Subject matters:
    • Economic Development
    • Health
  18. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Occurred: 2019-06-27
    Posted: 2019-07-15
    Designated public office holders:
    • Monique Lugli, Chief of Staff | Health Canada (HC)
    Subject matters:
    • Economic Development
    • Health
  19. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2019-05-09
    Posted: 2019-06-15
    Designated public office holders:
    • Ajandan Siviam, Advisor (Ontario), Small Business and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
    • Jason Easton, Chief of Staff, Small Business and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
  20. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Occurred: 2019-05-09
    Posted: 2019-06-12
    Designated public office holders:
    • Ajandan Sivam, Advisor, Regional Affairs (Ontario) and Stakeholder Relations, Small Business and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
    • Jason Easton, Chief of Staff, Small Business and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
  21. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2019-05-08
    Posted: 2019-06-15
    Designated public office holders:
    • David McFarlane, Director of Policy, Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Amanda Woodley, Policy Advisor, Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
  22. Teva Canada Ltd.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Occurred: 2019-05-08
    Posted: 2019-06-12
    Designated public office holders:
    • Amanda Woodley, Policy Advisor and Executive Assistant to the Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
  23. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2019-04-23
    Posted: 2019-05-15
    Designated public office holders:
    • Celia Lourenco, Director General, Biologics and Genetic Therapies Division (BGDT) | Health Canada (HC)
    Subject matters:
    • Health
  24. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2018-05-25
    Posted: 2018-06-15
    Designated public office holders:
    • Shaun Chen, Member of Parliament, Scarborough North | House of Commons
    Subject matters:
    • Economic Development
    • Health
    • Industry
  25. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2018-04-18
    Posted: 2018-05-15
    Designated public office holders:
    • Ginette Petitpas Taylor, Minister of Health | Health Canada (HC)
    • Genevieve Hinse, Chief of Staff, Office of the Minister of Health | Health Canada (HC)
    • Kathryn Nowers, Director of Policy, Office of the Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  26. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2017-12-01
    Posted: 2018-02-13
    Designated public office holders:
    • Philpott Jane, Minister, Indigenous Services | House of Commons
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
  27. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2017-09-26
    Posted: 2017-10-16
    Designated public office holders:
    • Mary Ng, Member of Parliament, Markham-Thornhill | House of Commons
    Subject matters:
    • International Trade
    • Intellectual Property
    • Industry
  28. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2017-09-25
    Posted: 2017-10-16
    Designated public office holders:
    • Jane Philpott, Minister, Indigenous Services, Indigenous and Northern Affairs Canada | House of Commons
    Subject matters:
    • Intellectual Property
    • Industry
  29. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2017-09-25
    Posted: 2017-10-16
    Designated public office holders:
    • Cary Seipp, Senior Trade Policy Officer | Global Affairs Canada (GAC)
    • Loris Mirella, Director - Intellectual Property Trade Policy | Global Affairs Canada (GAC)
    Subject matters:
    • Intellectual Property
  30. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2017-05-11
    Posted: 2017-06-15
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  31. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-11-16
    Posted: 2016-12-15
    Designated public office holders:
    • Navdeep Bains, Minister of Innovation, Science and Economic Development, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Parvinder Sachdeva, Policy Advisor, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Shaun Govender, Special Assistant - Regional Economic Development, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Intellectual Property
    • Industry
    • International Trade
  32. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-10-12
    Posted: 2016-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Intellectual Property
  33. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-07-14
    Posted: 2016-08-15
    Designated public office holders:
    • Anne Lamar, Assistant Deputy Minister, Regulatory Operations and Regions Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  34. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-06-07
    Posted: 2016-07-15
    Designated public office holders:
    • Jarrett Todd, Regulatory Officer | Patented Medicine Prices Review Board (PMPRB)
    • Ginette Tognet, Director, Regulatory Affairs & Outreach | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
  35. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-05-31
    Posted: 2016-06-15
    Designated public office holders:
    • Anil Arora, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  36. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-05-12
    Posted: 2016-06-15
    Designated public office holders:
    • Deborah Schulte, Member of Parliament | House of Commons
    • Don Davies, Member of Parliament | House of Commons
    • Lindsay Hunter, Ontario Regional Desk & Policy Advisor | Prime Minister's Office (PMO)
    • Len Webber, Member of Parliament | House of Commons
    • Hursh Jaswal, Special Assistant | Immigration, Refugees and Citizenship Canada (IRCC)
    • Bill Casey, Member of Parliament | House of Commons
    • Kathryn Nowers, Policy Advisor / Conseillère en politiques | Health Canada (HC)
    • Dev Saxena, Senior Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Jamie Kippen, Ontario Regional Desk & Policy Advisor | Prime Minister's Office (PMO)
    • Terence Scheltema, Member's Assistant | House of Commons
    Subject matters:
    • International Trade
    • Industry
    • Economic Development
    • Science and Technology
    • Health
    • Intellectual Property
  37. Teva Canada Limited / Teva Canada Limitee
    Type: Consultant
    Lobbyist: DONALD GRACEY, CG MANAGEMENT & COMMUNICATIONS
    Occurred: 2016-05-12
    Posted: 2016-05-19
    Designated public office holders:
    • Hursh Jaswal, Special Advisor | Immigration, Refugees and Citizenship Canada (IRCC)
    • Dev Saxena, Senior Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • John McCallum, Member of Parliament | House of Commons
    • Kathryn Nowers, Policy Advisor | Health Canada (HC)
    • Jamie Kippen, Ontario Desk | Prime Minister's Office (PMO)
    • Francesco Biondi-Morra, Special Advisor | Immigration, Refugees and Citizenship Canada (IRCC)
    • Navdeep Bains, Member of Parliament | House of Commons
    • Lindsay Hunter, Ontario Desk | Prime Minister's Office (PMO)
    • Colin Carrie, Member of Parliament | House of Commons
    • Bill Casey, Member of Parliament | House of Commons
    • Deborah Schulte, Member of Parliament | House of Commons
    • Len Webber, Member of Parliament | House of Commons
    • Don Davies, Member of Parliament | House of Commons
    • Shaun Chen, Member of Parliament | House of Commons
    Subject matters:
    • Economic Development
    • Health
  38. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-02-11
    Posted: 2016-03-15
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  39. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-12-22
    Posted: 2016-01-15
    Designated public office holders:
    • Brian Clow, Chief of Staff, Office of the Minister | Global Affairs Canada (GAC)
    • Dr. Jane Philpott, Minister of Health, Office of the Minister | Health Canada (HC)
    • Chrystia Freeland, Minister of International Trade, Office of the Minister | Global Affairs Canada (GAC)
    Subject matters:
    • International Trade
    • Industry
    • Intellectual Property
    • Health
  40. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-09-29
    Posted: 2015-10-15
    Designated public office holders:
    • Bruce Christie, Chief Air Negotiator/Director General | Foreign Affairs, Trade and Development Canada
    • Ed Fast, Minister of International Trade | Foreign Affairs, Trade and Development Canada
    • Andrea van Vugt, Chief of Staff | Foreign Affairs, Trade and Development Canada
    Subject matters:
    • Economic Development
    • International Trade
    • Intellectual Property
  41. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-07-21
    Posted: 2015-08-15
    Designated public office holders:
    • Idee Inyangudor, Director of Policy and Stakeholder Relations, Office of the Minister of International Development | Foreign Affairs, Trade and Development Canada
    • Candice Baetz, Policy Advisor, Office of the Minister of International Development | Foreign Affairs, Trade and Development Canada
    Subject matters:
    • Health
  42. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-07-20
    Posted: 2015-08-15
    Designated public office holders:
    • Christine Harmston, Manager, International Affairs, Multilateral Relations Division | Foreign Affairs, Trade and Development Canada
    • Gloria Wiseman, Director, Human Development and Gender Equality, Global Health Division | Foreign Affairs, Trade and Development Canada
    • Adrijana Corluka, Senior Policy Analyst, Global Health Division | Foreign Affairs, Trade and Development Canada
    • Susan Pierce, Director, Non-Insured Health Benefits Program | Health Canada (HC)
    Subject matters:
    • Health
  43. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-05-21
    Posted: 2015-06-15
    Designated public office holders:
    • Terrie Romano, Consul - Economic Affairs Ontario, Consulate of Canada | Foreign Affairs, Trade and Development Canada
    Subject matters:
    • Science and Technology
    • Health
    • Industry
  44. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-03-27
    Posted: 2015-04-15
    Designated public office holders:
    • Chris Lydon, Chief of Staff, Office of the Minister of Labour | Employment and Social Development Canada (ESDC)
    • Andrea van Vugt, Chief of Staff, Minister of International Trade | Foreign Affairs, Trade and Development Canada
    • Lois Brown, Member of Parliament, MP, Newmarket | House of Commons
    • Barbara Moran, Director, Controlled Substances and Tobacco Directorate, Healthy Environments and Consumer Safety Branch | Health Canada (HC)
    • Carolyn Bennett, Member of Parliament | House of Commons
    • David von Meyenfeldt, Director of Policy, Office of the Minister of State (Sport) | Canadian Heritage (PCH)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
  45. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2015-03-26
    Posted: 2015-04-15
    Designated public office holders:
    • Paul Calandra, Member of Parliment | House of Commons
    • Denis Martel, Director | Industry Canada
    • Francois Desmarais, Senior Policy Advisor | Industry Canada
    • John McCallum, Member of Parliament | House of Commons
    • Hedy Fry, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
    • Economic Development
    • Intellectual Property
  46. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2014-10-27
    Posted: 2014-11-15
    Designated public office holders:
    • Bill Hawkins, Chief of Staff, Minister of International Trade | Foreign Affairs, Trade and Development Canada
    • Kirsten Hillman, Associate Assistant Deputy Minister, Trade Agreements and Negotiations | Foreign Affairs, Trade and Development Canada
    Subject matters:
    • Industry
    • Intellectual Property
    • International Trade
  47. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2014-10-06
    Posted: 2014-11-15
    Designated public office holders:
    • Denis Martel, Director | Industry Canada
    Subject matters:
    • Economic Development
    • International Trade
    • Industry
  48. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2014-09-08
    Posted: 2014-10-15
    Designated public office holders:
    • Loris Mirella, Deputy Director - Intellectual Property Enforcement | Foreign Affairs, Trade and Development Canada
    Subject matters:
    • Industry
    • International Trade
    • Health
    • Intellectual Property
  49. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2014-08-19
    Posted: 2014-09-15
    Designated public office holders:
    • Paul Calandra, MP Stouffville, Parliamentary Secretary, PM and Intergovernmental Affairs | House of Commons
    Subject matters:
    • Economic Development
    • Industry
    • Intellectual Property
    • International Trade
    • Health
  50. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2014-08-18
    Posted: 2014-09-15
    Designated public office holders:
    • Erin O'Toole, MP Durham, Parliamentary Secretary, Minister of International Trade | House of Commons
    Subject matters:
    • International Trade
    • Intellectual Property
    • Industry
    • Economic Development
    • Health

Date Modified: